Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — if pharmaceutical companies would allow it.

Martin Whyte does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Readers respond to a guest essay by Keith Humphreys and an article about a fentanyl death. To the Editor: Re “Forced Drug Treatment Isn’t Horrific. It’s a Relief,” by Keith Humphreys (Opinion guest ...

During a Monday press conference about various autism topics, federal health officials noted the potential for an existing cancer drug to double as therapy for the neurodevelopmental condition. FDA ...

Targeted drug delivery is a powerful and promising area of medicine. Therapies that pinpoint the exact areas of the body ...

A new study by Michigan State University conducted with drug treatment programs in St. Clair County highlighted gaps the county faces in treating substance use disorder. The team of three researchers ...

FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (In Sept 22 story, corrects paragraph one to folinic acid from folic acid) (Reuters) -The U.S. Food and Drug ...

Could expensive drugs like Ozempic save healthcare systems money by reducing the risk of obesity-associated diseases? A new ...

Megan Funk can relate to anxiety that EMS providers might have regarding patient medication dosages, so she provides numerous tips and tricks to help ease that anxiety. One of the most important parts ...

A new drug has shown unprecedented promise in lowering blood pressure and preventing the progression of kidney disease for people with hard-to-treat hypertension. The medication, baxdrostat, reduces ...

Sept 22 (Reuters) - (This Sept 22 story has been corrected to say folinic acid, not folic acid, in paragraph 1) The U.S. Food and Drug Administration announced approval of leucovorin, or folinic acid, ...

New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) and published simultaneously in The Lancet shows that a ...